TIGIT and neoplasm: In mouse models, blocking TIGIT individually has little effect on survival and tumor growth, but the combination of aPD-L1 and anti-TIGIT (aTIGIT) has shown complete response with prolonged survival, as well as better efficacy than aPD-(L)1 alone [97].